[
    [
        {
            "time": "2018-03-15",
            "original_text": "Four months after CEO's death, biotech company names Lilly vet as leader",
            "features": {
                "keywords": [
                    "CEO's death",
                    "biotech",
                    "Lilly",
                    "leader"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Four months after CEO's death, biotech company names Lilly vet as leader",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-04-10",
            "original_text": "One Analyst Thinks AbbVie Is Grossly Undervalued",
            "features": {
                "keywords": [
                    "Analyst",
                    "AbbVie",
                    "Undervalued"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "One Analyst Thinks AbbVie Is Grossly Undervalued",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-05-22",
            "original_text": "AstraZeneca's Farxiga sNDA Gets Priority Review Status by FDA",
            "features": {
                "keywords": [
                    "AstraZeneca",
                    "Farxiga",
                    "FDA",
                    "Priority Review"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "AstraZeneca's Farxiga sNDA Gets Priority Review Status by FDA",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-06-18",
            "original_text": "4 GARP Stocks to Scoop Up for Maximum Returns",
            "features": {
                "keywords": [
                    "GARP Stocks",
                    "Maximum Returns"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "general"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "4 GARP Stocks to Scoop Up for Maximum Returns",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 4,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-07-03",
            "original_text": "If You Had Bought Eli Lilly (NYSE:LLY) Stock Five Years Ago, You Could Pocket A 88% Gain Today",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Stock",
                    "88% Gain"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "If You Had Bought Eli Lilly (NYSE:LLY) Stock Five Years Ago, You Could Pocket A 88% Gain Today",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        }
    ]
]